Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
DIGITAL MANAGEMENT OF HEART FAILURE IN AGING SOCIETIES: HEALTH SYSTEM TRANSFORMATION AND SOCIAL IMPLICATIONS - A NARRATIVE REVIEW
0
Zitationen
10
Autoren
2026
Jahr
Abstract
Heart failure (HF) represents a multisystem syndromic challenge that imposes significant clinical and economic burdens on aging societies, with global costs estimated at US $284.17 billion. Conventional hospital-centered care paradigms are limited by episodic and reactive frameworks that frequently fail to detect physiological decompensation during critical post-discharge phases. This narrative review synthesizes evidence focusing primarily on the 2016-2026 period, while integrating foundational seminal studies dating back to 2006, to evaluate the interdisciplinary impact of digital health interventions on HF management. Empirical findings demonstrate a fundamental shift toward proactive, pathophysiology-driven care supported by remote patient monitoring, implantable sensors, and artificial intelligence. Key clinical outcomes include a hazard ratio of 0.80 for unplanned hospitalizations in landmark telemedical trials and a 92.5% diagnostic accuracy for neural network models. Organizationally, hybrid "Hospital-at-Home" models and transition-of-care coaching have demonstrated significant reductions in readmissions. This review concludes that a sustainable digital transformation is contingent upon achieving alignment between technological capability, longitudinal economic reimbursement models, and robust governance to resolve the technological equity (“Techquity”) divide affecting high-risk aging populations.
Ähnliche Arbeiten
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
2021 · 19.543 Zit.
2013 ACCF/AHA Guideline for the Management of Heart Failure
2013 · 12.610 Zit.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · 12.555 Zit.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 · 11.735 Zit.
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
2002 · 11.655 Zit.